SEMA7A and influenza: We found a stronger response in healthy individuals compared with pre-treatment levels of patients regarding influenza antigen-induced CD4+ and CD4+CD108+ T cell responses (166 ± 247 versus 39 ± 85 and 9.7 ± 14 versus 3.6 ± 5.1, respectively, Figure 6 a).